Overview
ZNTL market data
Price History
ZNTL price chart · 1M
- O
- 3.84
- H
- 3.92
- L
- 3.83
- C
- 3.88
- Vol
- 39,750.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $3.84
- Previous Close
- $3.88
- Day High
- $3.92
- Day Low
- $3.83
- 52 Week High
- $5.57
- 52 Week Low
- $3.43
- 7 Day Return
- +1.31%
- 30 Day Return
- -15.94%
- 90 Day Return
- -3.13%
- 1 Year Return
- -2.15%
- Daily Notional Volume
- $154K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.91 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.95 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -246.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.21 – $6.95 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $316.6M · P/B 0.45.
Company News
Why Webull Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 20, 2026, 11:25 AM
Zentalis Pharmaceuticals shares are trading lower after the company announced the pricing of its $80.5 million proposed public offering of 23 million shares at $3.50 per share.Benzinga · Aug 14, 2026, 1:12 PM
12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · Aug 14, 2026, 12:06 PM
Reported Earlier, Zentalis Pharmaceuticals Prices Underwritten Public Offering Of 23M Shares At $3.50 Per Share, Expects $80.5M Gross ProceedsBenzinga · Aug 14, 2026, 5:09 AM
Zentalis Pharmaceuticals shares are trading lower after the company announced a proposed public offering.Benzinga · Aug 13, 2026, 8:25 PM
Zentalis Pharmaceuticals Announces Proposed Public Offering Of Shares And Pre-Funded WarrantsBenzinga · Aug 13, 2026, 8:05 PM
Rodman & Renshaw Initiates Coverage On Zentalis Pharmaceuticals with Buy Rating, Announces Price Target of $11Benzinga · Jul 23, 2026, 7:14 PM
Zentalis Pharmaceuticals shares are trading higher after Mizuho initiated its coverage on the stock with an Outperform rating and announced a price target of $8.Benzinga · Jul 17, 2026, 2:26 PM
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On FridayBenzinga · Jul 17, 2026, 2:09 PM
Mizuho Initiates Coverage On Zentalis Pharmaceuticals with Outperform Rating, Announces Price Target of $8Benzinga · Jul 17, 2026, 11:23 AM